Abstract
6078 Background: Immunotherapy with PD-1/PD-L1 axis blockade has shown promising preliminary results in patients with head and neck squamous cell carcinomas (HNSCC) (Seiwert ASCO 2014). Using a 12-...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have